Serum estradiol is associated with lean mass in elderly Swedish men.
暂无分享,去创建一个
[1] J. Carter. Sex hormone-binding globulin and risk of type 2 diabetes in women and men , 2010 .
[2] A. Meikle. Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men , 2010 .
[3] D. Lubahn,et al. Estrogen receptor-alpha and -beta and aromatase knockout effects on lower limb muscle mass and contractile function in female mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[4] T. Travison,et al. Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. , 2009, The Journal of clinical endocrinology and metabolism.
[5] S. Boonen,et al. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor‐α , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] B. Clarke. Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures , 2009 .
[7] A. Meikle. Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial , 2009 .
[8] L. Woodhouse,et al. Changes in Muscle Mass, Muscle Strength, and Power but Not Physical Function Are Related to Testosterone Dose in Healthy Older Men , 2008, Journal of the American Geriatrics Society.
[9] T. Travison,et al. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. , 2008, The Journal of clinical endocrinology and metabolism.
[10] A. Silman,et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. , 2008, The Journal of clinical endocrinology and metabolism.
[11] A. Tchernof,et al. Androgens and body fat distribution , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[12] W. Bremner,et al. Advances in male contraception. , 2008, Endocrine reviews.
[13] L. Lönn,et al. Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. , 2007, The Journal of clinical endocrinology and metabolism.
[14] P. H. Petersen,et al. Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. , 2007, The Journal of clinical endocrinology and metabolism.
[15] T. Travison,et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. , 2007, The Journal of clinical endocrinology and metabolism.
[16] Frederick C W Wu. Commentary: Guideline for male testosterone therapy: a European perspective. , 2007, The Journal of clinical endocrinology and metabolism.
[17] Claes Ohlsson,et al. Serum Levels of Specific Glucuronidated Androgen Metabolites Predict BMD and Prostate Volume in Elderly Men , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] S. Cummings,et al. Endogenous testosterone levels, physical performance, and fall risk in older men. , 2006, Archives of internal medicine.
[19] S. Cummings,et al. Comparison of methods to measure low serum estradiol levels in postmenopausal women. , 2006, The Journal of clinical endocrinology and metabolism.
[20] D. Grobbee,et al. Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men. , 2006, The Journal of clinical endocrinology and metabolism.
[21] P. Bélanger,et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women , 2006, The Journal of Steroid Biochemistry and Molecular Biology.
[22] V. Montori,et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.
[23] D. Kiel,et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. , 2006, The American journal of medicine.
[24] O. Johnell,et al. Free Testosterone is an Independent Predictor of BMD and Prevalent Fractures in Elderly Men: MrOS Sweden , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] J. Kaufman,et al. The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.
[26] R. Hansen. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS Study. , 2005, The American journal of clinical nutrition.
[27] Håkan Westerblad,et al. Difference in skeletal muscle function in males vs. females: role of estrogen receptor-beta. , 2004, American journal of physiology. Endocrinology and metabolism.
[28] J. Veldhuis,et al. Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. , 2004, The Journal of clinical endocrinology and metabolism.
[29] P. Delmas,et al. Role of sex steroids in the regulation of bone morphology in men. The MINOS study , 2004, Osteoporosis International.
[30] Christina Wang,et al. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. , 2004, The Journal of clinical endocrinology and metabolism.
[31] D. Blazer,et al. Testosterone and aging : clinical research directions , 2004 .
[32] Diederick E Grobbee,et al. Endogenous sex hormones in men aged 40-80 years. , 2003, European journal of endocrinology.
[33] W. Miller,et al. Aromatase in skeletal muscle , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[34] S. Boonen,et al. Evidence From the Aged Orchidectomized Male Rat Model That 17β‐Estradiol Is a More Effective Bone‐Sparing and Anabolic Agent Than 5α‐Dihydrotestosterone , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] E. Metter,et al. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. , 2002, American journal of physiology. Endocrinology and metabolism.
[36] Sundeep Khosla,et al. Sex steroids and the construction and conservation of the adult skeleton. , 2002, Endocrine reviews.
[37] R. Casaburi,et al. Testosterone dose-response relationships in healthy young men. , 2001, American journal of physiology. Endocrinology and metabolism.
[38] L. Melton,et al. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. , 2001, The Journal of clinical endocrinology and metabolism.
[39] D. Grobbee,et al. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. , 2000, The Journal of clinical endocrinology and metabolism.
[40] C. Bouchard,et al. Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. , 2000, The Journal of clinical endocrinology and metabolism.
[41] A. Vermeulen,et al. A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.
[42] Preston. Hormone containing growth promoting implants in farmed livestock. , 1999, Advanced drug delivery reviews.
[43] R. Baumgartner,et al. Predictors of skeletal muscle mass in elderly men and women , 1999, Mechanisms of Ageing and Development.
[44] Rudolph L. Leibel,et al. Medical progress: Obesity. , 1997 .
[45] L. Sjöström,et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. , 1990, Metabolism: clinical and experimental.
[46] P. Lundberg,et al. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. , 1986, Clinical chemistry.
[47] C. Longcope,et al. Aromatization of androgens by muscle and adipose tissue in vivo. , 1978, The Journal of clinical endocrinology and metabolism.